Description
The purpose of this session is to discuss lung cancer screening programs and to highlight challenges that may arise as the programs mature. Following the publication of the National Lung Screening Trial and subsequent USPSTF and CMS recommendations and coverage decisions, more and more practices and institutions are implementing CT lung cancer screening programs. The session will provide information on how to continue forward with lung cancer screening beyond just establishing a program. Topics include correctly using Lung-RADS, addressing 'gaps' in Lung-RADs, managing the screening process after the baseline screen, and implementing upcoming changes in the Fleischner Society recommendations for management of incidentally detected lung nodules. Developed in conjunction with The Fleischner Society and Society of Thoracic Radiology.
Learning Objectives:
- Identify solutions to common challenges encountered in establishing a lung cancer screening program.
- Discuss appropriate management recommendations and correctly use Lung-RADS to report lung cancer screening CT scans.
- Describe changes to lung nodule management based on the 2017 Fleischner Society guidelines.
Speaker(s):
- Geoffrey
Rubin,
MBA, MD, FACR
- Ella
Kazerooni,
MD, MS, FACR FSCBTMR
- Jeffrey
Kanne,
MD
- Florian
Fintelmann,
MD, FRCPC
- Maria
Martin,
MD
- Jared
Christensen,
MD
Disclosures
- Geoffrey Rubin, MBA, MD, FACR : Geoffrey Rubin, MBA, MD, FACR - Consultant - GE Healthcare|Fovia, Inc.; Stock Options - HeartFlow
- Ella Kazerooni, MD, MS, FACR FSCBTMR : Ella Kazerooni, MD, MS, FACR FSCBTMR - This speaker has nothing to disclose
- Jeffrey Kanne, MD : Jeffrey Kanne, MD - Consultant - Parexel International|HealthMyne
- Florian Fintelmann, MD, FRCPC : Florian Fintelmann, MD, FRCPC - Consultant - McKesson
- Maria Martin, MD : Maria Martin, MD - This speaker has nothing to disclose
- Jared Christensen, MD : Jared Christensen, MD - Consultant- Riverain Technologies, LLC
